Daratumumab (Darzalex) Injection from Mexico
Daratumumab (Darzalex) is a human monoclonal antibody targeting CD38, used for treating multiple myeloma. It is presented as an injection in measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This product directly regulates immunological processes in cancer therapy.
Duty Rate — Mexico → Canada
0%
Import Tips
• Ensure the injection is in retail packaging with measured doses
• Provide documentation of the product's immunological mechanism for customs
• Check if a Health Canada authorization is needed before import